Pharma Reviews: Morepen EGM approves Rs.433 cr incoming investment from Corinth and promoters

It is a testing time for life sciences and pharmaceutical companies, in these ... Speaking about the opportunities that the Indian market presents, Mr.
Read more: Morepen EGM approves Rs.433 cr incoming investment from Corinth and promoters